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Abstract
Positive evolutionary pressure has preserved the ability to synthesize chemically
authentic morphine, albeit in homeopathic concentrations, throughout animal
phyla. The prototype catecholamine dopamine (DA) serves as an essential
chemical intermediate in morphine biosynthesis both in plants and animals,
thereby providing considerable insight into the roles reciprocal “morphinergic”
and catecholamine regulation of diverse physiological processes. Primordial,
multi-potential cell types, before the emergence of specialized plant and animal
cells/organ systems, required selective mechanisms to limit their responsiveness
to environmental noise. Accordingly, cellular systems that emerged with the
potential for recruitment of the free radical gas nitric oxide (NO) as a multi-
faceted autocrine/paracrine signaling molecule were provided with extremely
positive evolutionary advantages. Endogenous “morphinergic” in concert with
NO-coupled signaling systems have evolved as autocrine/paracrine regulators
of metabolic homeostasis, energy metabolism, mitochondrial respiration and
energy production. Basic physiological processes involving “morphinergic”/NO-
coupled regulation of cardiovascular mitochondrial function, with special
emphasis on the interactive effects of ethanol, are discussed within the context
of our review.
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Introduction
Positive evolutionary pressure has apparently preserved the ability to
synthesize chemically authentic morphine, albeit in homeopathic
concentrations, throughout animal phyla [1-3]. Accordingly, the high level
of evolutionary conservation of morphine and related morphinan alkaloids
defines these molecules as essential chemical factors required for normal
growth and development [4]. Interestingly, dopamine (DA) serves as an
obligate chemical intermediate in the morphine biosynthetic pathway in
Papaver somniferum without assuming an independent role as the
prototype catecholamine signaling molecule with associated phenomena
[1, 5-9]. We have formulated a hypothesis stating that catecholamine-
expressing signaling systems emerged from the morphine biosynthetic
pathway via evolutionary adaptation of key enzymes involved in the
modification of L-tyrosine (L-TYR), DA, 3,4-dihydroxy-L-phenylalanine 
(L-DOPA), and tyramine (TA) [1-4]. 
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Operationally, catecholamine and endogenous
“morphinergic” signaling systems share a common
set of biosynthetic and metabolic enzymes,
indicating significant evolutionary retrofitting of
primordial enzyme species [2, 3, 10-12]. Mitochondria
arose via permanent enslavement of purple non-
sulphur bacteria as endosymbionts [13, 14].
Accordingly, primordial “morphinergic”/nitric oxide
(NO)-coupled signaling may have been instrumental
in the establishment of the mitochondrion as
a viable eukaryotic organelle. Aberrant “morphi  -
nergic”/NO-coupled regulatory events at the
mitochondrial level are proposed as causative
factors in a variety of pathophysiological states that
associated with very basic metabolic dysfunction.
Interestingly, we have observed that sub-threshold
concentrations of ethanol alter cellular distributions
of endogenously expressed morphine. Reciprocal
autocrine/paracrine modulatory effects of very low
concentrations of morphine in concert with ethanol
also suggest the potential for endogenous
expression and action of homeopathic con  -
centrations of ethanol within discrete cellular
microdomains, in particular mitochondria.
Functionally coupled catecholamine and
morphinergic expression in animal cells:
modulation by low levels of ethanol
Catecholamine signaling systems have evolved
as mainstay regulators of integrated physiological
and organ systems in animals, whereas
“morphinergic” signaling systems have evolved 
as autocrine/paracrine regulators of metabolic
homeostasis, energy metabolism, and mito  -
chondrial respiration [3, 4]. Homeopathic expression
of endogenous morphine appears to exert a state-
dependent down-regulation of cellular excitability
via highly specific receptor mediated processes
within a highly confined local circuitry [15-18]. In
a previous review, we have suggested that
evolutionary pressure drove an adaptive expansion
of catecholamine signaling systems in animal phyla
commensurate with the acquisition of complex
motor activities associated with complex feeding,
sexual and protective processes [4]. 
Previous work from our laboratory has
demonstrated that 1% ethanol engenders
a significant enhancement of cellular levels of
endogenous morphine when administered to in
vitro tissue preparations [6, 19, 20]. Whereas the
cellular effects of 1% ethanol may be functionally
linked to its anesthetic properties [21-25], a 100 fold
lower concentration of 2 mM ethanol, equivalent
to a non-activating, sensitizing, dose of 0.01% 
was observed to produce an effective doubling 
of 125I-trace labeled morphine released into the
extracellular medium. Because DA and its
immediate precursors L-TYR, L-DOPA, and TA also
serve as biosynthetic intermediates in cellular
morphine expression [26, 27], ethanol-mediated
anesthetic inhibition of dopamine signaling may
effectively divert excess precursor molecules to
cellular morphine pools. 
Endogenous morphine and nitric oxide-coupled
regulation of cardiovascular mitochondria 
We have proposed that the expression of
endogenous morphine by animal and human cells
is designed to mediate homeopathic regulation of
metabolic activity via activation of cognate µ3 and
µ4 receptors that serve as transductive conduits for
short-circuit Ca++ fluxes [28, 29]. Interactive
regulatory pathways employing endogenously
expressed morphine as an activating principle for
Ca2+-dependent, graded release of NO were
fashioned as a key cellular signaling molecule,
responsible for regulating intermediary metabolic
functions, including mitochondrial respiratory 
rate [30]. 
Cardiovascular physiology apparently involves
concerted regulatory activities of endogenous
morphine and NO at the cellular level. In an
ischemia-reperfusion rat model administration of
pharmacological dosages of morphine has been
shown to reduce infarct size in the myocardium and
promote improvement in cardiac function [31, 32].
Additionally, the protective effects of morphine have
been attributed to the opening of mitochondrial
K(ATP) channels in the myocardium [30, 33-38].
Subsequent studies have demonstrated that
morphine protects the myocardium against
ischemia-reperfusion injury via inhibition of
glycogen synthase kinase-3β (GSK-3β) and its
facilitation of mitochondrial permeability transition
pore opening (mPTP) [39, 40]. Operationally,
morphine protects the ischemic myocardium
against Ca2+-induced mPTP opening with
subsequent increases in mitochondrial resistance
and inactivation of GSK-3β via PI3-kinase mediated
events [40]. A recent review has indicated that
a major cardio-protective effect of morphine is
mediated through enhanced mitochondrial
hexokinase binding [41]. The authors speculate that
many cardio-protective interventions, including
ischemic preconditioning and morphine admi  -
nistration during postconditioning, direct cellular
redistribution and target mitochondrial of
hexokinase. 
Constitutive NO production and release protects
the ischemic heart from apoptosis and mito  -
chondrial dysfunction via protein kinase G-mediated
blockade of mPTP opening and cytochrome c re  -
lease [42] Furthermore, in a rat postconditioning
ischemia-reperfusion interactive positive effects of
morphine and constitutive NO were observed [43].
Extensive pharmacological controls using opiate
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receptor antagonists, constitutive nitric oxide
synthase (cNOS) and protein kinase inhibitors,
provided validating evidence for selectivity of effect
via concerted inhibition of mPTP opening by
morphine and activation of the cNOS-protein
kinase G pathway. A concerted pharmacological
approach has recently been developed to selectively
target NO donor compounds to mitochondria as an
efficacious strategy to modulate respiration and
protect mitochondria against ischemia-associated
reper  fusion injury [44]. 
Endogenous morphine and nitric oxide-coupled
regulation of cardiovascular mitochondria:
involvement of ethanol 
Our demonstration of dose dependent effects of
ethanol on endogenous morphine expression may
have profound implications for development of
novel therapeutic approaches for cardiovascular
protection. Epidemiological studies suggest that
light to moderate ethanol consumption not only
prevents ischemic cardiovascular damage but also
improves survival after myocardial infarction [45].
Clinical indications are complemented by a relatively
recent preclinical study investigating the interactive
protective effects of 2.5% ethanol on anesthetic
preconditioning in isolated guinea pig hearts [46].
The investigators demonstrated that infarct 
size was significantly reduced in anesthetic and
ethanol treated hearts, as compared to controls.
Importantly, the interactive effects of ethanol
resulted in enhanced opening of mitochondrial
K(ATP) channels and a coordinate increase in cNOS
expression with a reduction of inducible nitric oxide
synthase (iNOS) expression. In conclusion, reciprocal
autocrine/paracrine modulatory effects of very low
concentrations of morphine in concert with NO 
and ethanol suggest the potential for endogenous
expression and action of homeopathic concen  -
trations of ethanol within cardiovascular mito  -
chondria. 
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Figure 1. Human white blood cells have the ability to make and release morphine, which can have autocrine and
paracrine signaling functions. In the case of autocrine via cell surface µ3/4 receptors nitric oxide would be released
given its coupling to these mu opiate receptor subtypes. Additionally, µ opiate receptors, as noted in the text, are
on mitochondrial membranes. We speculate that the stimulated cellular NO can exert negative feedback actions
on the enzymes that make morphine and simultaneously negatively influence key mitochondrial energy associated
enzymes and processes, as noted in the figure, which when taken in total diminishes energy metabolism. In so
doing we surmise ROS and tissue damaging processes will be diminished, thus, morphine exerts an overall protective
effect. We also surmise, it is this morphinergic influence that may allow the mitochondria to be enslaved as a cellular
organelle via diminishing its ability to generate uncontrolled ROS and energy (from [7])
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